BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 21402485)

  • 1. Headache, menstruation and combined oral contraceptives: a diary study in 184 women with migraine.
    Lieba-Samal D; Wöber C; Frantal S; Brannath W; Schmidt K; Schrolnberger C; Wöber-Bingöl C;
    Eur J Pain; 2011 Sep; 15(8):852-7. PubMed ID: 21402485
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Headache induced by the use of combined oral contraceptives.
    Allais G; Gabellari IC; Airola G; Borgogno P; Schiapparelli P; Benedetto C
    Neurol Sci; 2009 May; 30 Suppl 1():S15-7. PubMed ID: 19415419
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prospective analysis of factors related to migraine attacks: the PAMINA study.
    Wöber C; Brannath W; Schmidt K; Kapitan M; Rudel E; Wessely P; Wöber-Bingöl C;
    Cephalalgia; 2007 Apr; 27(4):304-14. PubMed ID: 17376107
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Perimenstrual eletriptan prevents menstrual migraine: an open-label study.
    Marcus DA; Bernstein CD; Sullivan EA; Rudy TE
    Headache; 2010 Apr; 50(4):551-62. PubMed ID: 20236337
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of a contraceptive pill containing estradiol valerate and dienogest (E2V/DNG) in women with menstrually-related migraine (MRM).
    Nappi RE; Terreno E; Sances G; Martini E; Tonani S; Santamaria V; Tassorelli C; Spinillo A
    Contraception; 2013 Sep; 88(3):369-75. PubMed ID: 23453784
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Migraine associated with menstruation.
    MacGregor A
    Funct Neurol; 2000; 15 Suppl 3():143-53. PubMed ID: 11200785
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidemiological and clinical aspects of migraine in users of combined oral contraceptives.
    Machado RB; Pereira AP; Coelho GP; Neri L; Martins L; Luminoso D
    Contraception; 2010 Mar; 81(3):202-8. PubMed ID: 20159175
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sex hormones and headache.
    Silberstein SD
    Rev Neurol (Paris); 2000; 156 Suppl 4():4S30-41. PubMed ID: 11139745
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of migraine on patients and their families: the Migraine And Zolmitriptan Evaluation (MAZE) survey--Phase III.
    MacGregor EA; Brandes J; Eikermann A; Giammarco R
    Curr Med Res Opin; 2004 Jul; 20(7):1143-50. PubMed ID: 15265259
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral contraceptives in migraine.
    Allais G; Gabellari IC; De Lorenzo C; Mana O; Benedetto C
    Expert Rev Neurother; 2009 Mar; 9(3):381-93. PubMed ID: 19271947
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-migraine headache across the menstrual cycle in women with and without premenstrual syndrome.
    Keenan PA; Lindamer LA
    Cephalalgia; 1992 Dec; 12(6):356-9; discussion 339. PubMed ID: 1473137
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Scheduled short-term prevention with frovatriptan for migraine occurring exclusively in association with menstruation.
    Silberstein SD; Berner T; Tobin J; Xiang Q; Campbell JC
    Headache; 2009 Oct; 49(9):1283-97. PubMed ID: 19751371
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current perspectives on combination oral contraceptives.
    Smith MA; Youngkin EQ
    Clin Pharm; 1984; 3(5):485-96. PubMed ID: 6386284
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and tolerability of short-term preventive frovatriptan: a combined analysis.
    MacGregor EA; Brandes JL; Silberstein S; Jeka S; Czapinski P; Shaw B; Pawsey S
    Headache; 2009 Oct; 49(9):1298-314. PubMed ID: 19788471
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of sex hormones in headache.
    Silberstein SD
    Neurology; 1992 Mar; 42(3 Suppl 2):37-42. PubMed ID: 1557190
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Temporal relations in hormone-withdrawal migraines and impact on prevention- a diary-based pilot study in combined hormonal contraceptive users.
    Merki-Feld GS; Epple G; Caveng N; Imthurn B; Seifert B; Sandor P; Gantenbein AR
    J Headache Pain; 2017 Aug; 18(1):91. PubMed ID: 28842849
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A prospective comparison between ICHD-II and probability menstrual migraine diagnostic criteria.
    Marcus DA; Bernstein CD; Sullivan EA; Rudy TE
    Headache; 2010 Apr; 50(4):539-50. PubMed ID: 20236338
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Headache and female hormones: what you need to know.
    Silberstein SD
    Curr Opin Neurol; 2001 Jun; 14(3):323-33. PubMed ID: 11371755
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Menstrual cycle and headache in a population sample of migraineurs.
    Stewart WF; Lipton RB; Chee E; Sawyer J; Silberstein SD
    Neurology; 2000 Nov; 55(10):1517-23. PubMed ID: 11094107
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Headache and combination estrogen-progestin oral contraceptives: integrating evidence, guidelines, and clinical practice.
    Loder EW; Buse DC; Golub JR
    Headache; 2005 Mar; 45(3):224-31. PubMed ID: 15836597
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.